DNA And Gene Cloning Services Market Report 2026

DNA And Gene Cloning Services Market Overview

• DNA And Gene Cloning Services market size has reached to $3.06 billion in 2025 • Expected to grow to $5.79 billion in 2030 at a compound annual growth rate (CAGR) of 13.5% • Growth Driver: Impact Of Rising Gene Therapy Adoption • Market Trend: Revolutionizing Genome Editing Through AI-Driven Innovations • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under DNA And Gene Cloning Services Market?

Deoxyribonucleic acid (DNA) and gene cloning services refer to laboratory techniques used to create copies of specific DNA sequences or genes. These services involve inserting a gene of interest into a plasmid vector, which is then introduced into a host organism (such as bacteria) to replicate and produce multiple copies of the gene. This process is essential for various applications in research, medicine, and biotechnology. The main types of genes in the DNA and gene cloning services are standard gene, complex gene, and other types of genes. A standard gene is a well-defined gene with a known sequence and function, utilized as a reference or control in cloning procedures. The services offered include gene synthesis, custom cloning, subcloning, and others, applied in DNA sequencing, mutagenesis, and genotyping. These services cater to end users across academic and research and development (R&D), pharmaceutical and biotechnology companies, and others.

What Is The DNA And Gene Cloning Services Market Growth Forecast?

The dna and gene cloning services market size is expected to see rapid growth in the next few years. It will grow to $5.79 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to synthetic biology adoption, precision medicine research, biologics development growth, automation in molecular labs, global biotech investment. Major trends in the forecast period include growing demand for custom gene cloning services, increased use in drug discovery and development, expansion of synthetic and complex gene cloning, rising outsourcing by research institutions, adoption of high-throughput cloning technologies.

What Is The Driver Of The DNA And Gene Cloning Services Market?

The rise in gene therapy is expected to drive the growth of the DNA and gene cloning services market going forward. Gene therapy refers to a medical treatment approach that modifies, replaces, or introduces genes to prevent or treat diseases. The rise in gene therapy is increasing due to advancements in biotechnology, expanding clinical success in treating previously untreatable genetic disorders, and growing awareness among healthcare providers and patients. DNA and gene cloning services market supports this trend by enabling the precise genetic modifications, vector design, and engineered constructs required for developing effective gene therapy products. For instance, in April 2024, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit scientific organization, the number of phase III gene therapy clinical trials increased by 10% in Q4 2023, representing the first quarterly rise since Q3 2022. Therefore, the rise in gene therapy is driving the growth of the DNA and gene cloning services industry.

Key Players In The Global DNA And Gene Cloning Services Market

Major companies operating in the dna and gene cloning services market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Eurofins Scientific, Agilent Technologies Inc., Lonza Group, Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne, Curia Global Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Syngene International Limited, Twist Bioscience, New England Biolabs Inc., Origene Technologies Inc., MedGenome, Sino Biological, Genewiz Inc., Creative Biogene, Addgene.

Global DNA And Gene Cloning Services Market Trends and Insights

Major companies operating in the DNA and gene cloning services market are focusing on technological advancements such as artificial intelligence (AI)-generated gene editors to enhance editing accuracy, reduce development timelines, and streamline customized genetic modification workflows for research and therapeutic applications. An AI-generated gene editor refers to a gene-editing system designed or optimized using artificial intelligence models to create novel, highly precise CRISPR-like proteins capable of targeting and modifying genetic sequences with improved efficiency and flexibility. For instance, in April 2024, Profluent, a US-based biotechnology research company, launched OpenCRISPR-1, an AI-designed gene editor that enables precision genome editing through customizable CRISPR-like proteins created using large language models, significantly expanding CRISPR capabilities and marking a major advancement in next-generation genetic engineering.

What Are Latest Mergers And Acquisitions In The DNA And Gene Cloning Services Market?

In March 2025, Integrated DNA Technologies (IDT), a US-based company that provides DNA synthesis and gene cloning services, partnered with Elegen Corporation to provide early access to ENFINIA Plasmid DNA. With this partnership, IDT and Elegen aim to leverage their respective DNA synthesis technologies, combining IDT’s expertise in large-scale gene synthesis with Elegen’s cell-free plasmid DNA manufacturing platform to provide researchers and biotech companies with high-fidelity, long DNA constructs, ultimately accelerating synthetic biology and gene therapy applications. Elegen Corporation is a US-based biotechnology company that develops next-generation, cell-free DNA manufacturing solutions.

What Defines the DNA And Gene Cloning Services Market?

The DNA and gene cloning services market includes revenues earned by entities by providing services such as vector design and cloning, library construction, quality control and validation, plasmid preparation, and mutagenesis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the DNA And Gene Cloning Services Market Report 2026?

The dna and gene cloning services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dna and gene cloning services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.